» Articles » PMID: 38349932

Comparing the Effect of Intravenous Versus Intracranial Grafting of Mesenchymal Stem Cells Against Parkinsonism in a Rat Model: Behavioral, Biochemical, Pathological and Immunohistochemical Studies

Overview
Journal PLoS One
Date 2024 Feb 13
PMID 38349932
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative diseases worldwide. Currently applied therapeutic protocols are limited to improve the motor functions of patients. Therefore, seeking alternative regimes with better therapeutic impact is crucial. This study aims to validate the therapeutic impact of mesenchymal stem cell injection using two delivery methods, intracranial administration and intravenous administration, on rotenone (ROT)-induced PD model in rats. Our work included behavioral, biochemical, histological, and molecular investigations. Open field test (OFT) and rotarod tests were applied. Important oxidative stress, antioxidant and proinflammatory markers were monitored. Substantia Nigra and Striatum tissues were examined histologically and the molecular expression of DOPA decarboxylase, Tyrosine hydroxylase, and α-synuclein in neurons in these tissues were investigated. Our results showed that MSC grafting improved motor and memory impairments and oxidative stress status that were observed after ROT administration. Additionally, BM-MSCs application restored SOD and CAT activities and the levels of DA, L-Dopa, IL6, IL1β, and TNFα. Moreover, MSC grafting overwhelmed the pathological changes induced by ROT and normalized the expression of Tyrosine hydroxylase, DOPA decarboxylase, and α-synuclein towards the control values in the Nigral and Striatal tissues of male rats. Conclusively, both administration routes improved motor function, protection of the nigrostriatal system, and improved striatal dopamine release. The observed beneficial effect of applying MSCs suggests potential benefits in clinical applications. No significant differences in the outcomes of the treatment would favor a certain way of MSC application over the other. However, the intravenous delivery method seems to be safer and more feasible compared to the intrastriatal method.

Citing Articles

The protective efficacy of omega-3 polyunsaturated fatty acids on oxidative stress, inflammation, neurotransmitter perturbations, and apoptosis induced by monosodium glutamate in the brain of male rats.

Essawy A, Jimmiey E, Abdel-Wahab W, Ali R, Eweda S, Abdou H Metab Brain Dis. 2025; 40(1):114.

PMID: 39878784 PMC: 11779784. DOI: 10.1007/s11011-025-01539-4.


Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease.

Nagy N, Helal M, Alsawy E, Ali M, Al-Sherif S, Essawy A PLoS One. 2024; 19(12):e0315858.

PMID: 39693313 PMC: 11654954. DOI: 10.1371/journal.pone.0315858.

References
1.
Khayyat L, Essawy A, Sorour J, Soffar A . Sunset Yellow and Allura Red modulate Bcl2 and COX2 expression levels and confer oxidative stress-mediated renal and hepatic toxicity in male rats. PeerJ. 2018; 6:e5689. PMC: 6166620. DOI: 10.7717/peerj.5689. View

2.
Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

3.
Schiess M, Suescun J, Doursout M, Adams C, Green C, Saltarrelli J . Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease. Mov Disord. 2021; 36(8):1825-1834. PMC: 8451899. DOI: 10.1002/mds.28582. View

4.
Newman D, Cragg G . Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012; 75(3):311-35. PMC: 3721181. DOI: 10.1021/np200906s. View

5.
Essawy A, El-Sayed S, Tousson E, Abd El-Gawad H, Alhasani R, Abd Elkader H . Anti-kindling effect of Ginkgo biloba leaf extract and L-carnitine in the pentylenetetrazol model of epilepsy. Environ Sci Pollut Res Int. 2022; 29(32):48573-48587. PMC: 9252962. DOI: 10.1007/s11356-022-19251-6. View